DSS Stock Overview
Operates in the product packaging, biotechnology, commercial lending, securities and investment management, alternative trading, and direct marketing businesses. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
DSS, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.92 |
| 52 Week High | US$2.30 |
| 52 Week Low | US$0.77 |
| Beta | 1.78 |
| 1 Month Change | -0.65% |
| 3 Month Change | 11.58% |
| 1 Year Change | -52.37% |
| 3 Year Change | -93.06% |
| 5 Year Change | -99.32% |
| Change since IPO | -99.99% |
Recent News & Updates
Shareholder Returns
| DSS | US Commercial Services | US Market | |
|---|---|---|---|
| 7D | 9.7% | 2.6% | 2.8% |
| 1Y | -52.4% | 9.2% | 7.6% |
Return vs Industry: DSS underperformed the US Commercial Services industry which returned 10.3% over the past year.
Return vs Market: DSS underperformed the US Market which returned 8.1% over the past year.
Price Volatility
| DSS volatility | |
|---|---|
| DSS Average Weekly Movement | 10.1% |
| Commercial Services Industry Average Movement | 7.2% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 17.1% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: DSS has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: DSS's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 95 | Jason Grady | www.dssworld.com |
DSS, Inc. operates in the product packaging, biotechnology, commercial lending, securities and investment management, alternative trading, and direct marketing businesses. It manufactures, markets, and sells mailers, photo sleeves, custom folding cartons, and 3-dimensional direct mail solutions; and markets and distributes nutritional and personal care products. The company also invests in or acquires companies in the biohealth and biomedical fields, including businesses that focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune related diseases; and develops open-air defense initiatives for air-borne infectious diseases comprising tuberculosis and influenza.
DSS, Inc. Fundamentals Summary
| DSS fundamental statistics | |
|---|---|
| Market cap | US$6.47m |
| Earnings (TTM) | -US$67.80m |
| Revenue (TTM) | US$25.02m |
0.3x
P/S Ratio-0.1x
P/E RatioIs DSS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DSS income statement (TTM) | |
|---|---|
| Revenue | US$25.02m |
| Cost of Revenue | US$25.50m |
| Gross Profit | -US$481.00k |
| Other Expenses | US$67.32m |
| Earnings | -US$67.80m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -9.32 |
| Gross Margin | -1.92% |
| Net Profit Margin | -270.98% |
| Debt/Equity Ratio | 82.3% |
How did DSS perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/03/20 17:34 |
| End of Day Share Price | 2025/03/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
DSS, Inc. is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Rommel Dionisio | Aegis Capital Corporation |
| Han Jang | Aegis Capital Corporation |
| Robert Wasserman | Dawson James Securities |